Form D · Biotechnology

Instil Bio, Inc.

Dallas, TX · CIK 0001789769

Offering snapshot reported Feb 23, 2021 · SEC filing

Reported sold
$185M
Offering amount: $185M
Investors reported
26
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 30, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 23, 2021Initial$185,449,881No comparison26SEC filing
Aug 5, 2020Amendment$25,000,000$10,000,000vs Sep 30, 20191SEC filing
Aug 5, 2020Initial$515,917No comparison1SEC filing
Aug 5, 2020Initial$170,199,973No comparison15SEC filing
Sep 30, 2019Initial$15,000,000No comparison1SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-390158
Preferred Stock may convert to underlying shares of Common Stock.

Source: Form D, filed Feb 23, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gwen Binder Director
Bronson Crouch Director, Executive
Neil Gibson Director
Robert Hawkins Director
Sandeep Laumas Executive
George Matcham Director
Kent Mc Gaughy Director
Mariam Morris Executive
Jack Nielsen Director
Margo Roberts Director
Nimish Shah Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3963 Maple Avenue, Suite 350
Dallas, TX, 75219